文献速递肥胖与代谢综合征糖尿病

14天酮酯补充降低肥胖者血糖并改善血管功能:随机交叉试验

14-Day Ketone Supplementation Lowers Glucose and Improves Vascular Function in Obesity: A Randomized Crossover Trial.
PubMed 文献 · J Clin Endocrinol Metab · 2021-01-01

该随机交叉试验纳入14名肥胖成人,在每餐前15分钟补充酮单酯(12g β-羟丁酸)或安慰剂共14天。结果显示酮单酯使餐后血糖降低8.0%、24小时平均血糖降低7.8%,并改善肱动脉血流介导的舒张功能,且耐受性良好。

要点

  • 餐前补充酮单酯可降低肥胖成人餐后及24小时平均血糖。
  • 酮单酯改善血管内皮功能,可能降低心血管风险。
  • 酮单酯可能减少细胞炎症,但血浆细胞因子无变化。

核心结论

  • 在肥胖成人中,14天餐前酮单酯补充可改善血糖控制、增强血管功能并可能减少细胞炎症。

研究设计与样本

  • 随机交叉设计,14名肥胖成人(年龄56±12岁,BMI 32.8±7.7 kg/m2)接受酮单酯(12g β-羟丁酸)或安慰剂,每餐前15分钟服用,共14天,所有餐食统一提供。

主要发现

  • 酮单酯组餐后血糖较安慰剂组降低8.0%(g=0.735;P=0.011),24小时平均血糖降低7.8%(g=0.686;P=0.0001)。
  • 酮单酯组肱动脉血流介导的舒张功能从6.2±1.5%增至8.9±3.3%(g=1.05;P=0.0004),安慰剂组无变化(条件×时间交互P=0.004)。
  • 血浆细胞因子无变化,但酮单酯组脂多糖刺激的单核细胞caspase-1活化降低(刺激×条件×时间交互P=0.004)。
  • 酮单酯补充耐受性良好,依从性很高。

临床怎么用

  • 酮单酯补充可能作为改善肥胖者心血管代谢风险的非药物策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Postprandial hyperglycemia increases systemic inflammation and is a risk factor for cardiovascular disease. A ketone monoester (KME) drink containing β-hydroxybutyrate (β-OHB) rapidly lowers plasma glucose, which may be a strategy protecting against postprandial hyperglycemia. OBJECTIVE: We hypothesized that KME would attenuate 2-hour postprandial glucose, lower systemic inflammation, and improve vascular function in adults with obesity. METHODS: In a randomized crossover design, 14 participants with obesity (age = 56 ± 12 years; body mass index = 32.8 ± 7.7 kg/m2) consumed KME (12 g β-OHB) or placebo 15 minutes prior to each meal for 14 days with all meals provided and matched between conditions. Postprandial glycemia was assessed by continuous glucose monitoring. Vascular function and inflammation were assessed before and after treatment periods. RESULTS: Postprandial glucose was 8.0% lower in KME versus placebo (g = 0.735; P = 0.011) and 24-hour average glucose reduced by 7.8% (g = 0.686; P = 0.0001). Brachial artery flow-mediated dilation increased from 6.2 ± 1.5% to 8.9 ± 3.3% in KME (g = 1.05; P = 0.0004) with no changes in placebo (condition × time interaction, P = 0.004). There were no changes in plasma cytokines; however, lipopolysaccharide-stimulated monocyte caspase-1 activation was lower following KME supplementation versus placebo (stimulation × condition × time interaction; P = 0.004). The KME supplement was well tolerated by participants and adherence to the supplementation regimen was very high. CONCLUSIONS: In adults with obesity, 14 days of premeal KME supplementation improves glucose control, enhances vascular function, and may reduce cellular inflammation. KME supplementation may be a viable, nonpharmacological approach to improving and protecting vascular health in people with heightened cardiometabolic risk.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Walsh JJ, Neudorf H, Little JP, et al. 14-Day Ketone Supplementation Lowers Glucose and Improves Vascular Function in Obesity: A Randomized Crossover Trial. J Clin Endocrinol Metab. 2021. PMID: 33367782. doi:10.1210/clinem/dgaa925

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。